FDA approves Medtronic’s CoreValve FDA approved Medtronic PLC ’s CoreValve self-expanding transcatheter aortic valve implant (TAVI) system for patients with severe aortic stenosis patients who ar
If Ampersand Medical Corp. , a point-of-care (POC) cancer-screening company ( See "Ampersand Medical Corp. , START-UP, October 2000 [A#2000900175), was started with an unusual financing strategy, i
Each year in the US, an estimated 1.2 million people are diagnosed with cancer. More than half a million died of it in 1999. The disease, which costs the US economy $107 billion per year, according to
Biomolecular markers take the subjectivity out of cervical cancer screening The market for cervical cancer screening technologies is crowded with competition and fraught with failures, but it is still